ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GSK And Aptuit Extend Partnership

by Michael McCoy
November 19, 2012 | APPEARED IN VOLUME 90, ISSUE 47

[+]Enlarge
Credit: Aptuit
A statue in the lobby of Aptuit’s Verona facility.
09047-buscon-Veronacxd.jpg
Credit: Aptuit
A statue in the lobby of Aptuit’s Verona facility.

GlaxoSmithKline and the contract research firm Aptuit have agreed to a multiyear extension of a drug development partnership at Aptuit’s facility in Verona, Italy. Aptuit acquired the facility from GSK in 2010 as the drug company was shrinking its R&D footprint. Aptuit Chairman Timothy C. Tyson says the extension reaffirms the Verona site’s ability to deliver scientific excellence. The site has developed more than 90 other clients, he adds.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment